Health
The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS – GlobeNewswire
Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form of ALS,…
- Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form of ALS, a progressive neurodegenerative dise…
Continue Reading
-
Business23 hours ago2 ASX shares I’d buy for a year-end breakout
-
Noosa News23 hours agoInside the struggle between location and dream home
-
Noosa News20 hours agoNew seller disclosure laws expected to redefine property deals in Queensland
-
Noosa News22 hours agoDental clinic is needed | Noosa Today